• Consensus Rating: Moderate Buy
  • Consensus Price Target: C$8.33
  • Forecasted Upside: 12.46%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$7.41
▼ -0.13 (-1.72%)

This chart shows the closing price for EXE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Extendicare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EXE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EXE

Analyst Price Target is C$8.33
▲ +12.46% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Extendicare in the last 3 months. The average price target is C$8.33, with a high forecast of C$8.50 and a low forecast of C$8.00. The average price target represents a 12.46% upside from the last price of C$7.41.

This chart shows the closing price for EXE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 polled investment analysts is to moderate buy stock in Extendicare. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/1/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/28/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/28/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/28/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/21/2024Royal Bank of CanadaBoost TargetSector PerformC$8.00 ➝ C$8.50
5/17/2024TD SecuritiesBoost TargetHoldC$7.50 ➝ C$8.00
3/11/2024Leede Jones GableBoost TargetBuyC$7.00 ➝ C$8.50
3/11/2024TD SecuritiesBoost TargetHoldC$7.00 ➝ C$7.50
3/11/2024Royal Bank of CanadaBoost TargetSector PerformC$7.50 ➝ C$8.00
11/13/2023Leede Jones GabUpgradeHold ➝ Buy
5/9/2023Royal Bank of CanadaBoost TargetSector PerformC$7.00 ➝ C$7.50
5/9/2023National BanksharesBoost TargetSector PerformC$7.00 ➝ C$7.50
3/6/2023Royal Bank of CanadaLower TargetSector PerformC$7.50 ➝ C$7.00
1/30/2023National BanksharesLower TargetSector PerformC$7.50 ➝ C$7.00
11/17/2022Royal Bank of CanadaLower TargetSector PerformC$8.00 ➝ C$7.50
10/24/2022National BanksharesLower TargetC$8.00 ➝ C$7.50
10/20/2022TD SecuritiesLower TargetHoldC$7.50 ➝ C$7.00
6/27/2022CIBCLower TargetC$8.50 ➝ C$8.00
3/3/2022Royal Bank of CanadaBoost TargetSector PerformC$8.00 ➝ C$8.50
2/28/2022CIBCBoost TargetNeutralC$8.25 ➝ C$8.50
2/7/2022TD SecuritiesReiterated RatingHoldC$8.00
11/15/2021Royal Bank of CanadaLower TargetSector PerformC$8.50 ➝ C$8.00
11/9/2021Laurentian Bank of CanadaReiterated RatingHold
11/8/2021Laurentian Bank of CanadaLower TargetC$8.00
11/8/2021TD SecuritiesLower TargetHoldC$8.50 ➝ C$8.00
11/8/2021LaurentianLower TargetC$8.75 ➝ C$8.00
11/1/2021CIBCReiterated RatingNeutralC$8.25
8/9/2021Laurentian Bank of CanadaBoost TargetC$8.25 ➝ C$8.75
8/9/2021LaurentianBoost TargetC$8.25 ➝ C$8.75
7/19/2021National BanksharesBoost TargetC$8.50 ➝ C$9.00
7/19/2021National Bank FinancialBoost TargetNAC$9.00
5/21/2021Royal Bank of CanadaBoost TargetSector PerformC$7.00 ➝ C$8.50
5/18/2021Laurentian Bank of CanadaBoost TargetHoldC$8.25
5/18/2021LaurentianBoost TargetC$7.00 ➝ C$8.25
5/17/2021National Bank FinancialBoost TargetNAC$8.50
5/17/2021National BanksharesBoost TargetSector PerformC$8.00 ➝ C$8.50
5/14/2021TD SecuritiesBoost TargetHoldC$7.00 ➝ C$8.00
3/1/2021Leede Jones GabReiterated RatingBuy
3/1/2021National Bank FinancialReiterated RatingSector PerformC$6.50 ➝ C$7.00
12/1/2020National Bank FinancialBoost TargetSector PerformC$7.00
11/25/2020National Bank FinancialBoost TargetSector PerformC$6.00 ➝ C$7.00
11/19/2020National Bank FinancialBoost TargetSector PerformC$6.00 ➝ C$7.00
11/16/2020CIBCBoost TargetC$7.00 ➝ C$7.25
8/19/2020Laurentian Bank of CanadaLower TargetC$8.00 ➝ C$6.00
8/19/2020LaurentianLower TargetC$8.00 ➝ C$6.00
8/18/2020Royal Bank of CanadaLower TargetSector PerformC$7.50 ➝ C$7.00
7/30/2020CIBCLower TargetC$8.00 ➝ C$7.00
5/22/2020Royal Bank of CanadaLower TargetSector PerformC$7.75 ➝ C$7.50
5/19/2020Laurentian Bank of CanadaDowngradeBuy ➝ HoldC$10.00 ➝ C$8.00
5/19/2020National Bank FinancialLower TargetSector PerformC$7.00 ➝ C$6.00
5/19/2020TD SecuritiesLower TargetHoldC$7.00 ➝ C$6.50
5/19/2020LaurentianDowngradeBuy ➝ HoldC$10.00 ➝ C$8.00
4/29/2020CIBCDowngradeOutperform ➝ NeutralC$8.50 ➝ C$8.00
4/14/2020National Bank FinancialLower TargetSector PerformC$8.50 ➝ C$7.00
4/2/2020Royal Bank of CanadaLower TargetSector PerformC$8.75 ➝ C$7.75
3/30/2020CIBCLower TargetC$9.50 ➝ C$8.50
3/3/2020Royal Bank of CanadaLower TargetSector PerformC$9.00 ➝ C$8.75
3/2/2020Echelon Wealth PartnersUpgradeHold ➝ Buy
3/2/2020National Bank FinancialLower TargetSector PerformC$9.00 ➝ C$8.50
11/11/2019Echelon Wealth PartnersDowngradeBuy ➝ Hold
10/16/2019National Bank FinancialBoost TargetSector PerformC$8.50 ➝ C$9.00
8/20/2019Royal Bank of CanadaBoost TargetSector PerformC$8.50 ➝ C$9.00
8/19/2019Echelon Wealth PartnersUpgradeHold ➝ Buy
(Data available from 5/28/2019 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/29/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/28/2024

Current Sentiment

  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Extendicare logo
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Read More

Today's Range

Now: C$7.41
Low: C$7.38
High: C$7.53

50 Day Range

MA: C$7.48
Low: C$7.24
High: C$7.88

52 Week Range

Now: C$7.41
Low: C$5.75
High: C$8.04

Volume

118,578 shs

Average Volume

135,027 shs

Market Capitalization

C$617.85 million

P/E Ratio

18.07

Dividend Yield

6.44%

Beta

1.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Extendicare?

The following equities research analysts have issued research reports on Extendicare in the last year: Leede Jones Gab, Leede Jones Gable, Royal Bank of Canada, and TD Securities.
View the latest analyst ratings for EXE.

What is the current price target for Extendicare?

3 Wall Street analysts have set twelve-month price targets for Extendicare in the last year. Their average twelve-month price target is C$8.33, suggesting a possible upside of 12.5%. Royal Bank of Canada has the highest price target set, predicting EXE will reach C$8.50 in the next twelve months. TD Securities has the lowest price target set, forecasting a price of C$8.00 for Extendicare in the next year.
View the latest price targets for EXE.

What is the current consensus analyst rating for Extendicare?

Extendicare currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for EXE.

What other companies compete with Extendicare?

How do I contact Extendicare's investor relations team?

Extendicare's physical mailing address is 3000 Steeles Avenue East, Suite 700, Markham, ON L3R 4T9, Canada. The company's listed phone number is 905-470-4000. The official website for Extendicare is www.extendicare.com. Learn More about contacing Extendicare investor relations.